Literature DB >> 30145986

Screening of Serum Biomarkers for Distinguishing between Latent and Active Tuberculosis Using Proteome Microarray.

Shu Hui Cao1, Yan Qing Chen2, Yong Sun3, Yang Liu4, Su Hua Zheng4, Zhi Guo Zhang5, Chuan You Li2.   

Abstract

OBJECTIVE: To identify potential serum biomarkers for distinguishing between latent tuberculosis infection (LTBI) and active tuberculosis (TB).
METHODS: A proteome microarray containing 4,262 antigens was used for screening serum biomarkers of 40 serum samples from patients with LTBI and active TB at the systems level. The interaction network and functional classification of differentially expressed antigens were analyzed using STRING 10.0 and the TB database, respectively. Enzyme-linked immunosorbent assays (ELISA) were used to validate candidate antigens further using 279 samples. The diagnostic performances of candidate antigens were evaluated by receiver operating characteristic curve (ROC) analysis. Both antigen combination and logistic regression analysis were used to improve diagnostic ability.
RESULTS: Microarray results showed that levels of 152 Mycobacterium tuberculosis (Mtb)-antigen- specific IgG were significantly higher in active TB patients than in LTBI patients (P < 0.05), and these differentially expressed antigens showed stronger associations with each other and were involved in various biological processes. Eleven candidate antigens were further validated using ELISA and showed consistent results in microarray analysis. ROC analysis showed that antigens Rv2031c, Rv1408, and Rv2421c had higher areas under the curve (AUCs) of 0.8520, 0.8152, and 0.7970, respectively. In addition, both antigen combination and logistic regression analysis improved the diagnostic ability.
CONCLUSION: Several antigens have the potential to serve as serum biomarkers for discrimination between LTBI and active TB.
Copyright © 2018 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  Active TB; LTBI; Proteome microarray; Serum biomarkers

Mesh:

Substances:

Year:  2018        PMID: 30145986     DOI: 10.3967/bes2018.069

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  9 in total

Review 1.  Immune Biomarkers for Diagnosis and Treatment Monitoring of Tuberculosis: Current Developments and Future Prospects.

Authors:  Yean K Yong; Hong Y Tan; Alireza Saeidi; Won F Wong; Ramachandran Vignesh; Vijayakumar Velu; Rajaraman Eri; Marie Larsson; Esaki M Shankar
Journal:  Front Microbiol       Date:  2019-12-18       Impact factor: 5.640

Review 2.  Recent advances in the detection of interferon-gamma as a TB biomarker.

Authors:  Kaylin Cleo Januarie; Onyinyechi V Uhuo; Emmanuel Iwuoha; Usisipho Feleni
Journal:  Anal Bioanal Chem       Date:  2021-10-19       Impact factor: 4.142

Review 3.  A systematic review of potential screening biomarkers for active TB disease.

Authors:  James H Wykowski; Chris Phillips; Thao Ngo; Paul K Drain
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-11-05

Review 4.  Host and Bacterial Iron Homeostasis, an Underexplored Area in Tuberculosis Biomarker Research.

Authors:  Lucinda Baatjies; Andre G Loxton; Monique J Williams
Journal:  Front Immunol       Date:  2021-10-29       Impact factor: 7.561

Review 5.  Using Omics to Study Leprosy, Tuberculosis, and Other Mycobacterial Diseases.

Authors:  Naseem Ahamad; Saurabh Gupta; Deepak Parashar
Journal:  Front Cell Infect Microbiol       Date:  2022-02-24       Impact factor: 5.293

6.  Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB.

Authors:  Zhihui Li; Jianjun Hu; Pengchong Liu; Dan Cui; Hongqin Di; Shucai Wu
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

7.  Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection.

Authors:  Yun-Jeong Kang; Heechul Park; Sung-Bae Park; Junseong Kim; Jiyoung Lee; Jungho Kim; Sunyoung Park; Yong Sung Lee; Sunghyun Kim
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-06-22

8.  Serum proteomic analysis of Mycobacterium tuberculosis antigens for discriminating active tuberculosis from latent infection.

Authors:  Zhangli Peng; Ling Chen; Hong Zhang
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

Review 9.  Pediatric Tuberculosis: The Impact of "Omics" on Diagnostics Development.

Authors:  Shailja Jakhar; Alexis A Bitzer; Loreen R Stromberg; Harshini Mukundan
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.